These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2612560)
1. DOI is a mixed agonist-antagonist at postjunctional 5-HT2 receptors in the pithed rat. Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H Eur J Pharmacol; 1989 Oct; 170(1-2):109-11. PubMed ID: 2612560 [TBL] [Abstract][Full Text] [Related]
2. Characterization of DOI, a putative 5-HT2 receptor agonist in the rat. Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Laubie M; Schmitt H Eur J Pharmacol; 1989 Sep; 168(3):369-74. PubMed ID: 2583242 [TBL] [Abstract][Full Text] [Related]
3. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat. Chaouche-Teyara K; Fournier B; Safar M; Dabiré H Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025 [TBL] [Abstract][Full Text] [Related]
4. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat. Deckert V; Chaouloff F; Richer C; Elghozi JL Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665 [TBL] [Abstract][Full Text] [Related]
6. Comparison between ketanserin and LY 53857 on vascular and cardiac 5-HT2 and alpha 1-adrenergic receptors in the pithed rat. Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H Arch Int Pharmacodyn Ther; 1990; 306():57-64. PubMed ID: 1981667 [TBL] [Abstract][Full Text] [Related]
7. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors. Rittenhouse PA; Bakkum EA; Van de Kar LD J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135 [TBL] [Abstract][Full Text] [Related]
8. Vascular postsynaptic effects of some 5-HT1-like receptor agonists in the pithed rat. Dabiré H; Cherqui C; Fournier B; Schmitt H Eur J Pharmacol; 1988 May; 150(1-2):143-8. PubMed ID: 2900152 [TBL] [Abstract][Full Text] [Related]
9. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms. Dedeoğlu A; Fisher LA J Pharmacol Exp Ther; 1991 Dec; 259(3):1027-34. PubMed ID: 1762059 [TBL] [Abstract][Full Text] [Related]
10. Evidence that activation of 5-HT2 receptors in the forebrain of anaesthetized cats causes sympathoexcitation. Anderson IK; Martin GR; Ramage AG Br J Pharmacol; 1995 Sep; 116(2):1751-6. PubMed ID: 8528555 [TBL] [Abstract][Full Text] [Related]
11. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat. Chaouloff F; Laude D; Baudrie V Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400 [TBL] [Abstract][Full Text] [Related]
12. Investigations of cardiovascular 5-hydroxytryptamine receptor subtypes in the rat. Docherty JR Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):1-8. PubMed ID: 3368008 [TBL] [Abstract][Full Text] [Related]
13. Can the 5-HT2/1c agonist DOI cause differential sympatho-excitation in nerves supplying the heart in anaesthetized cats? Ramage AG; Shepheard SL; Jordan D; Koss MC J Auton Nerv Syst; 1993 Jan; 42(1):53-62. PubMed ID: 8436806 [TBL] [Abstract][Full Text] [Related]
14. Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat. Villalón CM; Contreras J; Ramírez-San Juan E; Castillo C; Perusquía M; Terrón JA Br J Pharmacol; 1995 Dec; 116(8):3330-6. PubMed ID: 8719815 [TBL] [Abstract][Full Text] [Related]
15. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. Marek GJ; Aghajanian GK J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525 [TBL] [Abstract][Full Text] [Related]
16. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist. Pranzatelli MR Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895 [TBL] [Abstract][Full Text] [Related]
17. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat. Cohen ML; Fuller RW; Kurz KD J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists. Bagdy G; Sved AF; Murphy DL; Szemeredi K Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317 [TBL] [Abstract][Full Text] [Related]
19. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats. Anderson IK; Martin GR; Ramage AG Br J Pharmacol; 1992 Dec; 107(4):1020-8. PubMed ID: 1467825 [TBL] [Abstract][Full Text] [Related]
20. Chronic 5-HT2 receptor blockade with ritanserin does not reduce blood pressure in the spontaneously hypertensive rat. Gradin K; Pettersson A; Hedner T; Persson B J Neural Transm; 1985; 64(2):145-9. PubMed ID: 2934513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]